MARKET RADAR
SENSEX     NIFTY      
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
541.30
-0.65 (-0.12%)
VOLUME 35,752
LIVE
NSE
Feb 10, 17:00
541.45
-1.3 (-0.24%)
VOLUME 955,167
News on Sun Pharmaceutical Industries
Select Year: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Sun Pharma Q3 PAT seen up 65% at Rs 576 cr

10.36 am | 11 Feb 2012 |  Source: CNBC-TV18

Sun Pharmaceutical Industries, country's largest drugmaker by market cap, is set to announce its results for the quarter ended December FY12 on Monday...

Market on a roll: Kotak bets on CIL, ONGC, Sterlite

10.22 am | 07 Feb 2012 |  Source: CNBC-TV18

Indian market is rallying with full might gaining 15% alone in 2012. Experts are hopeful that this rally will continue for some more time. So, till it...

Be wise; Don't take a position in market today: Sukhani 

9.59 am | 31 Jan 2012 |  Source: CNBC-TV18

Profit booking after a stellar performance in the last four weeks, has Sudarshan Sukhani of s2analytics telling CNBC-TV18’s viewers that today is one ...

Buy Sun Pharma on dips: Sukhani 

9.13 am | 31 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics is of the view that one can buy Sun Pharma....

Bull's Eye: 12 buying ideas for the day 

11.20 am | 20 Jan 2012 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Buy Sun Pharmaceutical, says Sukhani 

9.08 am | 20 Jan 2012 |  Source: CNBC-TV18

Buy Sun Pharmaceutical, says Sudarshan Sukhani, s2analytics.com....

Now is not an entry point but time to exit at 5100: Sukhani 

8.58 am | 20 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com spoke to CNBC-TV18 about his expectations of the market now. The Nifty yesterday crossed the 5000 with ease, but ...

Super Six trading ideas for the day 

8.35 am | 20 Jan 2012 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment Pvt ltd, Nooresh Mirani - AVP Technical, AMSEC R...

Pharma Q3: New launches, generic drug demand to aid growth

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

4860-4880 is a key resistance for Nifty: Anil Manghnani 

9.56 am | 13 Jan 2012 |  Source: CNBC-TV18

Anil Manghnani, Modern Shares & Stock Brokers says, 4,860-4,880 is a key resistance for the Nifty. “I wouldn’t want to take a fresh call, unless I see...

Bull's Eye: Short Infosys, ICICI Bank; buy Sun Pharma 

11.52 am | 12 Jan 2012 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

Hold Sun Pharma, says Sukhani 

9.09 am | 11 Jan 2012 |  Source: CNBC-TV18

Hold Sun Pharma, says Sudarshan Sukhani of s2analytics.com....

Stay away from Nifty, be stock specific: Sudarshan Sukhani 

8.25 am | 11 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani, s2analytics.com says, the Nifty should be left alone and one should focus on individual stocks....

Pharmaceutical results preview for Q3FY12: Emkay

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

Stocks in news: Orchid Chem, OM Metals, IOB, Reliance Power

8.08 am | 09 Jan 2012 |  Source: CNBC-TV18

Orchid Chemical | OM Metals Infraprojects | GMR | IOB | Kingfisher | Reliance Power | Strides Arcolab and Vakrangee Software are stocks, which are in ...

Cheap valuations reason behind India upgrade: Credit Suisse 

8.54 am | 06 Jan 2012 |  Source: CNBC-TV18

For 16 months, Credit Suisse had been underweight India. The investment bank's Asia-Pacific strategist Sakthi Siva says when they downgraded India in ...

Credit Suisse upgrades domestic markets to neutral

8.00 pm | 04 Jan 2012 |  Source: PTI

Global financial services major Credit Suisse today upgraded the domestic equity markets from underweight to neutral as valuation has come down to att...

Unicon recommends 8 stocks for long term investment

12.33 pm | 28 Nov 2011 |  Source: Moneycontrol.com

Unicon Investment has come out with its report on leveraged companies. The broking firm has identified have identified 8 companies with strong growth ...

Buy Sun Pharma; target Rs 569: Angel Broking

1.27 pm | 23 Nov 2011 |  Source: Moneycontrol.com

Angel Broking is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 569 in its November 16, 2011 research rep...

Limited competition, Forex gains pump Taro nos: Sun Pharma 

2.29 pm | 14 Nov 2011 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Uday Baldota of Sun Pharma says the results of Taro, have been boosted by lack of competition and Forex gains. With 'ver...

1 2
Quick Links for Sun Pharmaceutical Industries
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.